These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19191213)

  • 1. Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine.
    Morris E; Green D; Graudins A
    J Med Toxicol; 2009 Mar; 5(1):27-31. PubMed ID: 19191213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In response to Morris et al.'s "Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine".
    Gillman K
    J Med Toxicol; 2009 Dec; 5(4):259. PubMed ID: 20012252
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
    Musselman ME; Browning LA; Parker D; Saely S
    Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome associated with olanzapine therapy: a case report.
    Stanfield SC; Privette T
    J Emerg Med; 2000 Nov; 19(4):355-7. PubMed ID: 11074330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl.
    Erermis S; Bildik T; Tamar M; Gockay A; Karasoy H; Ercan ES
    Clin Toxicol (Phila); 2007; 45(3):277-80. PubMed ID: 17453880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome and atypical antipsychotic drugs.
    Ananth J; Parameswaran S; Gunatilake S; Burgoyne K; Sidhom T
    J Clin Psychiatry; 2004 Apr; 65(4):464-70. PubMed ID: 15119907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine induced neuroleptic malignant syndrome.
    Patra BN; Khandelwal SK; Sood M
    Indian J Pharmacol; 2013; 45(1):98-9. PubMed ID: 23543750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.
    Stevens DL; Lee MR; Padua Y
    Pharmacotherapy; 2008 Mar; 28(3):403-5. PubMed ID: 18294120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.
    Järventausta K; Leinonen E
    Acta Psychiatr Scand; 2000 Sep; 102(3):231-3. PubMed ID: 11008860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroleptic malignant syndrome after treatment with olanzapine].
    Emborg C
    Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome associated with olanzapine.
    Filice GA; McDougall BC; Ercan-Fang N; Billington CJ
    Ann Pharmacother; 1998 Nov; 32(11):1158-9. PubMed ID: 9825080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome secondary to olanzapine, a presentation with severe acute kidney injury requiring hemodialysis: a case report.
    Chang CK; Payus AO; Noh MM; Lansing MG; Sumpat D; Lu SJA; Yew BT
    J Med Case Rep; 2022 Oct; 16(1):366. PubMed ID: 36203196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An atypical case of neuroleptic malignant syndrome precipitated by valproate.
    Verma R; Junewar V; Rathaur BP
    BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24604797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine].
    Hanel RA; Sandmann MC; Kranich M; De Bittencourt PR
    Arq Neuropsiquiatr; 1998 Dec; 56(4):833-7. PubMed ID: 10029891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Asenapine overdose leading to Neuroleptic Malignant Syndrome (NMS).
    Das S; Purushothaman ST; Bc M; Chatterjee SS; Kartha A; Rajan V
    Asian J Psychiatr; 2017 Dec; 30():31-32. PubMed ID: 28711682
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic.
    Abu-Kishk I; Toledano M; Reis A; Daniel D; Berkovitch M
    J Toxicol Clin Toxicol; 2004; 42(6):921-5. PubMed ID: 15533033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine induced neuroleptic malignant syndrome--a case review.
    Kogoj A; Velikonja I
    Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Life threatening neuroleptic malignant syndrome due to olanzapine].
    Kopf A; Köster J; Schulz A; Krömker H; Becker T
    Psychiatr Prax; 2003 Jul; 30(5):279-82. PubMed ID: 12872187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.